Switch to
View more

Bal Pharma Ltd

BALPHARMA
Health CarePharmaceuticals
SmallcapWith a market cap of ₹150 cr, stock is ranked 1,891
High RiskStock is 3.16x as volatile as Nifty
96.550.70 (-0.72%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹150 cr, stock is ranked 1,891
High RiskStock is 3.16x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
26.80
PB RatioPB Ratio
2.82
Dividend YieldDiv. Yield
0.99%
Sector PESector PE
34.62
Sector PBSector PB
4.37
Sector Div YldSctr Div Yld
0.92%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Bal Pharma Limited is engaged in the manufacture and sale of pharmaceutical products. The Company’s business comprises of Active Pharmaceutical Ingredients (API), Finished Formulations, Ayurvedic, Research and Development.

Financial TrendFinancial statements 

2019202020212022226.02172.94251.67286.373.80-12.224.745.61
Revenue
Profit
Loss
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Increased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has increased by 2.43%

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Newspaper Advertisements 
Announced OnAug 16, 2022

Bal Pharma Limited has informed the Exchange about Newspaper Advertisements of Unaudited financial results of the Company for the quarter ended 30.06.2022. | Download

Bal Pharma Limited has informed the Exchange about Newspaper Advertisements of Unaudited financial results of the Company for the quarter ended 30.06.2022. | Download

Press Release 
Announced OnAug 12, 2022

Bal Pharma Limited has informed the Exchange about press release dated 12-Aug-2022 titled Bal Pharma Ltd announces Q1FY23 financial results | Download

Bal Pharma Limited has informed the Exchange about press release dated 12-Aug-2022 titled Bal Pharma Ltd announces Q1FY23 financial results | Download

Cash Dividend 
Ex. DateSep 16, 2021

Final • Div/Share: ₹ 1

See all events